ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval Cohort
Sponsor: Symetis SA
Listed as NCT03003650, this NA trial focuses on Symptomatic Aortic Stenosis and remains completed. Sponsored by Symetis SA, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Nov 2018 — Dec 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Mar 2018 [monthly]
Active Not Recruiting PHASE2
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Symetis SA
For direct contact, visit the study record on ClinicalTrials.gov .